Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective
Yuan GaoKey Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, PR China; Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, PR China; Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, PR China; College of Pharmacy, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, PR China; School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510000, PR ChinaHang ZhangKey Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, PR China; Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, PR China; Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, PR China; College of Pharmacy, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, PR China; School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510000, PR China; Department of Basic Medicine, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, PR ChinaFrédéric LirussiINSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France; Université de Bourgogne-Franche Comté, I-SITE, France; University Hospital of Dijon (CHU), FranceCarmen GarridoINSERM, U1231, Label LipSTIC, and Ligue Nationale contre le Cancer, Dijon, France; Université de Bourgogne-Franche Comté, I-SITE, France; Anti-cancer Center George-François Leclerc, CGFL, Dijon, France. Electronic address: [email protected]Xiang‐Yang YeKey Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, PR China; Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, PR China; Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, PR China; College of Pharmacy, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, PR China. Electronic address: [email protected]Tian XieKey Laboratory of Elemene Class Anti-Cancer Chinese Medicine of Zhejiang Province, PR China; Engineering Laboratory of Development and Application of Traditional Chinese Medicine from Zhejiang Province, PR China; Collaborative Innovation Center of Chinese Medicines from Zhejiang Province, PR China; College of Pharmacy, School of Medicine, Hangzhou Normal University, Hangzhou, Zhejiang 311121, PR China. Electronic address: [email protected]
2020en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references